Over the years of activity of the European Inhibitor Network, we have collected and shared a good amount of knowledge, information and good practices. One to the most urgent unmet needs for the population of the ultra rare bleeding disorder patients is more knowledge about their bleeding disorder: we have started to gather useful information and resources – but this work is only in the beginning.
